A phase II prospective study of the trastuzumab combined with 5-weekly S-1 and CDDP therapy for HER2-positive advanced gastric cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Yoshinori Mori Takaya Shimura |
| Publication date | March 22, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |